Toronto Dominion Bank Medicenna Therapeutics Corp. Transaction History

Toronto Dominion Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Feb 14, 2024	BUY	$0.28 - $0.51 $320 - $584	1,146 Added 215.82%	1,677 $0
Q3 2023 Nov 14, 2023	BUY	$0.28 - $0.51 $320 - $584	1,146 Added 215.82%	1,677 $0
Q2 2023 Feb 14, 2024	BUY	$0.44 - $0.82 $233 - $435	531 New	531 $0
Q2 2023 Aug 10, 2023	BUY	$0.44 - $0.82 $23 - $44	54 Added 11.32%	531 $0
Q1 2023 May 11, 2023	BUY	$0.5 - $0.78 $238 - $372	477 New	477 $0
Q3 2022 Nov 09, 2022	SELL	$0.83 - $1.78 $22,412 - $48,065	-27,003 Reduced 92.78%	2,100 $2,000
Q2 2022 Aug 11, 2022	BUY	$0.79 - $1.32 $21,510 - $35,940	27,228 Added 1452.16%	29,103 $33,000
Q1 2022 May 09, 2022	BUY	$1.26 - $1.92 $2,362 - $3,600	1,875 New	1,875 $3,000

863K

Ticker MDNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,637,504
Market Cap $21.6M
Description
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.